UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely AGTC is implementing good security practices.
The Applied Genetic Technologies Corporation is a publicly traded (NASDAQ: AGTC) biotechnology company that is part of the NASDAQ Biotechnology Index. It was founded in 1999 and has its headquarters in Alachua, Florida. The company focuses on ophthalmologic genetic diseases. The company's technologies are aimed at products that might have the potential to treat achromatopsia, X-linked retinoschisis, X-linked retinitis pigmentosa, and age-related macular degeneration.
This report shows a preliminary security rating for AGTC. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
The average cost of a data breach is now nearly $4 million, and the unfortunate truth is ...
An exploit is a piece of software, data or sequence of commands that takes advantage of a ...
Compare AGTC's security performance with other companies